Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
45 /100
COMPONENT-LIMITED
Score updated Oct 13, 2026

DRUG — Bright Minds Biosciences Inc. Dilution Risk Tracker

Track DRUG dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DRUG — Get alerts when the score changes →

As of October 13, 2026, Bright Minds Biosciences Inc. (DRUG) has a DilutionWatch DilutionScore of 45/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Bright Minds Biosciences Inc. has a market capitalization of $244.35M, 4.52M shares outstanding, 93 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊Float Risk—
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for DRUG.
🔔 Track DRUG — Get forecast alerts →

Market Data

Market Cap$244.35M
Shares Outstanding4.52M
FloatN/A
Cash$224.50M
Debt$59.5K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore45/100DilutionWatch score record
Shares Outstanding4.52MVerified float table or market cache
Public FloatNot availableVerified float table or market cache
Market Cap$244.35MMarket data cache
Cash RunwayNot availableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 0.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 79.7% shares (2026Q1 vs prior)
93 institutional holders · 11.89M shares
#1 JANUS HENDERSON GROUP PLC 2.57M shares
#2 Vivo Capital, LLC 1.11M shares
#3 Cormorant Asset Management, LP 1.06M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest882.8K
Days to Cover8.5
% of FloatN/A
FINRA data as of Sep 30, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news available for this ticker.

DilutionScore History — Last 90 Days

DRUG's DilutionScore has held steady at 45/100 (Medium risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202645/100MEDIUM89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

DRUG shares outstanding have decreased 0.0% from 9.79M (May 2026) to 9.79M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 22, 20269.79M5.17M▲ 0.23%
May 21, 20269.79M5.16M▲ 0.25%
May 18, 20269.79M5.15M▼ 22.88%
May 17, 20269.79M6.68M▼ 0.83%
May 04, 20269.79M6.73M▲ 1.81%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track DRUG Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment DRUG files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking DRUG — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for DRUG
DRUG FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.